Zobrazeno 1 - 10
of 76
pro vyhledávání: '"R P, Baughman"'
Autor:
Eleni Bibaki, R P Baughman, George A. Margaritopoulos, Elyse E. Lower, Maria Bolaki, Katerina M. Antoniou
Publikováno v:
Güncel Göğüs Hastalıkları Serisi. 5:98-109
Publikováno v:
Lung. 198(6)
The Saint George's Respiratory Questionnaire (SGRQ) is a frequently used tool to assess health status in pulmonary disease patients. However, its performance characteristics in sarcoidosis patients are not well characterized.Data from a clinical tria
Publikováno v:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 32(4)
Autor:
W P E, de Kleijn, M D P, Elfferich, J, De Vries, G J, Jonker, E E, Lower, R P, Baughman, T E, King, M, Drent
Publikováno v:
Sarcoidosis Vasculitis and Diffuse Lung Diseases. 26(2):92-97
Background. Fatigue is a major problem in sarcoidosis. Fatigue has mainly been examined in patients from the Netherlands. Objective: The aims of the study were to establish the prevalence of fatigue in US and Dutch patients and to determine whether f
Publikováno v:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 30(3)
Publikováno v:
The Journal of Immunology. 158:1930-1940
alpha 2-Macroglobulin (alpha 2m) is a major plasma proteinase inhibitor, as well as a carrier and regulator of the function of many cytokines. IL-8 is a potent neutrophil attractant and activator, and it plays an important role in the pathogenesis of
Publikováno v:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 30(2)
Sarcoidosis associated hypercalcemia (SAHC) may be secondary to excessive levels of 1,25-(OH)2 vitamin D3 produced by autonomous 1-alpha-hydroxylase activity within the granulomas. The frequency, treatment, and consequences of hypercalcemia remain un
Autor:
R P, Baughman
Publikováno v:
Panminerva medica. 55(2)
The treatment of pulmonary sarcoidosis is based on several factors. These include changes in pulmonary physiology, presence of extra-pulmonary disease, and symptoms. Several immunosuppressive agents have been studied and recommendations regarding the
Autor:
Aleksandra Dudvarski-Ilić, Vladimir Zugic, Mira Vukovic, Mihailo Stjepanovic, Elyse E. Lower, Spasoje Popevic, Maja Omcikus, Branislav Gvozdenovic, R P Baughman, Snežana Filipović, Jelica Videnovic-Ivanov, Violeta Mihailovic-Vucinic
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 17(4)
OBJECTIVES To assess the impact of high body mass index (BMI) on patient-reported outcomes in sarcoidosis patients and healthy persons. METHODS In this case-control study, we investigated symptoms of fatigue and dyspnoea, health status, BMI and spiro
Publikováno v:
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG. 29(1)
Sarcoidosis is a granulomatous disorder of unknown cause, affecting multiple organs. Tuberculosis is the world's second most common cause of death from infectious diseases. Due to the similar clinical, radiological and histopathological pictures in s